866 results on '"J. Riera"'
Search Results
52. A state-space model of the hemodynamic approach: nonlinear filtering of BOLD signals.
- Author
-
Jorge J. Riera, Jobu Watanabe, Kazuki Iwata, Naoki Miura, Eduardo Aubert, Tohru Ozaki, and Ryuta Kawashima
- Published
- 2004
- Full Text
- View/download PDF
53. 1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
- Author
-
S. Lorenzen, P.C. Thuss-Patience, G. Folprecht, J. Riera Knorrenschild, V. Heinemann, E. Goekkurt, T.N. Dechow, T.J. Ettrich, K.B. Luley, J-C. Moulin, U. Lindig, S. Angermeier, O. Waidmann, D. Pink, C. Bolling, S. Junge, C. Pauligk, T. Gaiser, T.O. Götze, and S-E. Al-Batran
- Subjects
Oncology ,Hematology - Published
- 2022
54. 680P HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany
- Author
-
C. Langer, E. von der Heyde, D.A. Hahn, B. Kubuschok, U. Bockmühl, H. Mueller-Huesmann, G. Klautke, J. von der Grün, D. Beutner, J. Büntzel, C-J. Busch, B.F. Tamaskovics, J. Riera Knorrenschild, K. Gutsche, M.K. Welslau, T.C. Gauler, D. Waldenberger, and A. Dietz
- Subjects
Oncology ,Hematology - Published
- 2022
55. Penile nodules as a manifestation of lymphogranuloma venereum: an underrecognized form
- Author
-
Y. Zboromyrska, N. Castrejón, J. Riera-Monroig, Irene Fuertes, Adriana García-Herrera, Francesc Alamon-Reig, and Priscila Giavedoni
- Subjects
Male ,medicine.medical_specialty ,business.industry ,Lymphogranuloma venereum ,Chlamydia trachomatis ,Dermatology ,medicine.disease ,Infectious Diseases ,Lymphogranuloma Venereum ,medicine ,Humans ,Homosexuality, Male ,business ,Penis - Published
- 2021
56. LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)
- Author
-
Stein, A., primary, Paschold, L., additional, Tintelnot, J., additional, Goekkurt, E., additional, Thuss-Patience, P.C., additional, Lorenzen, S., additional, Ettrich, T.J., additional, Knorrenschild, J. Riera, additional, Jacobasch, L., additional, Kretzschmar, A., additional, Kubicka, S., additional, Al-Batran, S-E., additional, Reinacher-Schick, A., additional, Pink, D., additional, Sinn, M., additional, Lindig, U., additional, Hinke, A., additional, Hegewisch Becker, S., additional, and Binder, M., additional
- Published
- 2021
- Full Text
- View/download PDF
57. Screening for asymptomatic Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium in medical students in Barcelona
- Author
-
Evelin L. Corbeto, J. Riera-Monroig, Jordi Bosch, and Irene Fuertes
- Subjects
Sexual partner ,Medical knowledge ,medicine.medical_specialty ,biology ,Obstetrics ,business.industry ,medicine.disease_cause ,biology.organism_classification ,Asymptomatic ,Chlamydia trachomatis+Neisseria gonorrhoeae ,Vaginal swabs ,Neisseria gonorrhoeae ,medicine ,medicine.symptom ,business ,Chlamydia trachomatis ,Mycoplasma genitalium - Abstract
Objectives: No previous studies had been performed on asymptomatic sexually transmitted infections (STIs) in Spanish university students. Therefore, the aim of the study was to determine the prevalence of Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Mycoplasma genitalium (MG) in this group. Material and Methods: All medical students were invited to participate in the study between September 2017 and June 2019. First-void urine specimens were collected from men and vaginal swabs from women. Results: Four females had positive results. The prevalence of CT and MG in women was 4.0% and 2.4%. All individuals with positive results had stable partners. CT infection was associated with having stable and sporadic sexual partner in the previous year. The frequency of positive results was higher in those women who had sought an app-based sexual partner. Conclusion: The prevalence of asymptomatic STI in medical students was similar (rather than lower) to that in same age individuals in the area. Medical knowledge might not protect from STI acquisition.
- Published
- 2020
58. Eccrine syringofibroadenoma as a clue for the diagnosis of Schöpf‐Schulz‐Passarge syndrome in acquired palmoplantar keratoderma
- Author
-
Encarnación Guillén‐Navarro, J. M. Mascaró, Llucia Alos, María del Carmen Martínez‐Romero, and J. Riera-Monroig
- Subjects
Pathology ,medicine.medical_specialty ,Histology ,Administration, Topical ,Biopsy ,Acquired palmoplantar keratoderma ,Dermatology ,Eccrine Glands ,Eyelid Neoplasms ,Hypotrichosis ,Pathology and Forensic Medicine ,Keratoderma, Palmoplantar ,Humans ,Medicine ,Anodontia ,Eccrine syringofibroadenoma ,business.industry ,Homozygote ,Eyelids ,Exons ,Middle Aged ,medicine.disease ,Wnt Proteins ,Sweat Gland Neoplasms ,Schöpf–Schulz–Passarge syndrome ,Fibroadenoma ,Mutation ,Eyelid Diseases ,Female ,business - Published
- 2020
59. Rupioid psoriasis induced by pembrolizumab
- Author
-
Sara Gómez, Cristina Carrera, J. Riera-Monroig, José M. Mascaró, and Ignasi Marti-Marti
- Subjects
medicine.medical_specialty ,Infectious Diseases ,Rupioid psoriasis ,business.industry ,MEDLINE ,lcsh:Dermatology ,Medicine ,Dermatology ,Pembrolizumab ,lcsh:RL1-803 ,business - Published
- 2020
60. Nonlinear EEG analysis based on a neural mass model.
- Author
-
Pedro A. Valdés-Hernández, Juan C. Jiménez, Jorge J. Riera, Rolando J. Biscay, and Tohru Ozaki
- Published
- 1999
- Full Text
- View/download PDF
61. Fully-Passive Wireless Implant for Neuropotential Acquisition: An In Vivo Validation
- Author
-
Lakshmini Balachandar, Satheesh Bojja-Venkatakrishnan, Carolina Moncion, John L. Volakis, and Jorge J. Riera
- Subjects
Radiation ,Computer science ,business.industry ,Minimum detectable signal ,0206 medical engineering ,Impedance matching ,020206 networking & telecommunications ,Ranging ,02 engineering and technology ,020601 biomedical engineering ,0202 electrical engineering, electronic engineering, information engineering ,Wireless ,Radiology, Nuclear Medicine and imaging ,Detection theory ,Radio frequency ,business ,Instrumentation ,Wireless sensor network ,Sensitivity (electronics) ,Biomedical engineering - Abstract
Implantable systems are often employed to perform continuous high-resolution recordings of neural activity. These systems frequently require invasive procedures when implanting and maintaining effective operation. This causes major interruptions to daily life. Previous work demonstrated an in vitro minimum detectable signal of 15 μ V in amplitude and RF sensitivity down to –135 dBm. This suggests the possibility of detecting diminutive biopotentials in a wireless fully passive manner. Here, for the first time, we validate the wireless neurosensing system through a series of in vivo electrophysiological recordings including both spontaneous cardiac activity and sensory evoked neural activity, with amplitudes ranging from a few microvolts to millivolts and across a spectrum of frequencies. We also present design considerations and the development of probes for neurosensing to accomplish detectability of biopotentials in the tens of microvolts in rats. The developed probes show improved impedance matching with the neurosensing system. Specifically, the new probes showed an impedance several orders of magnitude lower than those commercially available, thereby significantly improving signal detection. Notably, the presented in vivo validation of this technology has great future clinical implications in neuroscience as it offers a wireless and unobtrusive device for neurological research, monitoring, and therapeutic purposes.
- Published
- 2019
62. Epilepsy Focus Localization in Patients Utilizing BOLD Differences Related to Regional Metabolic Dynamics
- Author
-
Prasanna Jayakar, P. Valdés, Byron Bernal, Jorge J. Riera, Nolan Altman, Magno R. Guillen, and Michael Duchowny
- Subjects
Low oxygen ,Focus (geometry) ,business.industry ,medicine.disease ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Electrophysiology ,Epilepsy ,0302 clinical medicine ,Neuroimaging ,030220 oncology & carcinogenesis ,Medicine ,Ictal ,Epilepsy surgery ,In patient ,business ,Neuroscience - Abstract
This paper presents a theoretical elaboration aimed to explain the correlation found between a new rs-fMRI modality and electrophysiology and nuclear medicine neuroimaging, performed to localize epileptogenic brain areas. We present in detail the clinical history, and electrophysiological and neuroimaging results of one child with intractable epilepsy, who was submitted for Phase-1 work-up as candidate for epilepsy surgery. The patient underwent a thorough workup including video-telemetry, ictal and interictal nuclear medicine imaging, resting-state fMRI, EEG-fMRI, intracranial electroencephalography (ECoG), deep electrode implantation, and resective surgery. Electrophysiology and neuroimaging findings were concordant with findings provided by the resting-state mean signal. The patient became seizure-free after the resection of the target area. A theoretical discussion is provided that considers the presence of a stable BOLD effect explaining the findings of the observed resting-state mean signal. This stable BOLD is linked to low regional metabolism usually present in the epileptogenic area during interictal periods, coupled with low oxygen extraction. Low oxygen extraction leaves more oxygen for the draining venule and consequently increases the BOLD signal.
- Published
- 2019
63. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry
- Author
-
D P Ruiz-Genao, Gregorio Carretero, Esteban Daudén, L Rodriguez, Enrique Herrera-Ceballos, P. de la Cueva, F.J. Gómez-García, J Vilar-Alejo, Conrad Pujol-Marco, José Manuel Carrascosa, Antonio Sahuquillo-Torralba, Isabel Belinchón, Miguel Ángel Descalzo, M. Ferran, Ignacio García-Doval, J Riera-Monroig, Mar Llamas-Velasco, Enrique Herrera-Acosta, O Baniandrés-Rodríguez, Raquel Rivera, Mónica Munera-Campos, José L. López-Estebaranz, Lula María Nieto-Benito, F Ballescá, Mercè Alsina, and C García-Donoso
- Subjects
Drug ,medicine.medical_specialty ,media_common.quotation_subject ,adverse event ,Dermatology ,liver ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Non-alcoholic Fatty Liver Disease ,Psoriasis ,Internal medicine ,Nonalcoholic fatty liver disease ,Medicine ,Humans ,Prospective Studies ,Registries ,Prospective cohort study ,Adverse effect ,media_common ,risk ,030203 arthritis & rheumatology ,business.industry ,Incidence (epidemiology) ,medicine.disease ,Methotrexate ,Tumor Necrosis Factor Inhibitors ,business ,hepatic ,psoriasis treatment ,medicine.drug - Abstract
BACKGROUND: Limited information is available regarding the risk of incident liver disease in patients with psoriasis receiving systemic therapies. OBJECTIVES: To describe the liver safety findings of conventional and modern systemic therapies for moderate-to-severe psoriasis, and to compare the relative incidence rates of hepatic adverse events (AEs) for each drug. METHODS: All the patients on the BIOBADADERM registry were included. Crude and adjusted incidence rate ratios (cIRR and aIRR, respectively) of hepatic AEs, using anti-TNF drugs as reference, were determined. Outcomes of interest were hypertransaminasemia, nonalcoholic fatty liver disease (NADFLD) and a group of other, less represented, hepatic AEs. RESULTS: Our study included 3,171 patients exposed to systemic drugs (6279 treatment cycles). Incident hypertransaminasemia was the most frequent hepatic AE (incidence rate of 21 per 1000 patients-years [CI 95% CI 18-23]), followed by NAFLD (8 cases per 1000 patients-years [95% CI 6-10]). Methotrexate (aIRR 3.06 [2.31-4.4]; p = 0.000) and cyclosporine (aIRR 2.37 [1.05-5.35]; p = 0.0378) were associated with an increased risk for hypertransaminasemia when compared to anti-TNF-a agents. No differences were observed between different groups of biologics. Conventional therapies were not associated with new incident NAFLD. CONCLUSIONS: Comparative information of the incidence of hepatic AEs could facilitate drug selection in moderate-to-severe psoriasis.
- Published
- 2021
64. 1430P Frequency of PD-L1 positivity and microsatellite instability (MSI) in the DANTE trial: Perioperative atezolizumab with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma. A randomized, open-label phase IIb trial of the German gastric group at the AIO and SAKK
- Author
-
M. Schenk, Timo Gaiser, U. Lindig, Natsumi Irahara, Albrecht Kretzschmar, Alexander Rheinhard Siebenhuener, C. Kopp, Nils Homann, Eray Goekkurt, Sylvie Lorenzen, T.O. Götze, Claudia Pauligk, J. Riera Knorrenschild, S-E. Al-Batran, Lisa Waberer, Peter C. Thuss-Patience, R.D. Hofheinz, G.M. Haag, V. Heuer, and Claus Bolling
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Microsatellite instability ,Hematology ,Perioperative ,medicine.disease ,Gastroenterology ,PHASE IIB TRIAL ,Oncology ,Atezolizumab ,PD-L1 ,Internal medicine ,biology.protein ,Medicine ,Adenocarcinoma ,In patient ,Open label ,business - Published
- 2021
65. Acerca del deporte y el deportista
- Author
-
J. Riera
- Subjects
lcsh:Psychology ,lcsh:BF1-990 - Abstract
La investigación en psicología del deporte suele dar prioridad a la búsqueda de pautas generales para mejorar la preparación del deportista, mientras que en la práctica los psicólogos ajustan estos procedimientos a las peculiaridades de las situaciones deportivas y a las características del deportista. Por ello, se exponen criterios para clasificar las diferentes modalidades deportivas a partir de la identificación de las habilidades que el deportista ha de aprender. Posteriormente, se comentan las principales características del deportista que influyen en su aprendizaje y rendimiento en el deporte. Finalmente, se sugieren varias áreas de investigación e intervención, y se defiende la conveniencia de no olvidar la individualidad del deportista en el ejercicio profesional del psicólogo del deporte Research in psychology tends to search for general procedures which will improve the preparation of the sportsman. However in practice the psychologist adjusts these procedures to the peculiarities and characteristics of the situation and the sportsman. Thus the clasification of the different sport disciplines according to criteria which identify the habilities that the sportman has to learn, will be described. Furthermore, the principle personal characteistics of the sportsman which affects its learning abilities and output, will be commented. Finally, various areas of research and its application wil be suggested and that the applied sport psychologist should not overlook the individuality of the sportsman will be defended
- Published
- 2021
66. Family-based intervention to prevent childhood obesity among school-age children of low socioeconomic status : study protocol of the FIVALIN project
- Author
-
P. Berruezo, R. Milà, Helmut Schröder, Lidia Estrada, J. de Bont, Santiago F. Gomez, G. Según, Clara Homs, E. Carrillo-Álvarez, and J. Riera-Romaní
- Subjects
Gerontology ,Adult ,medicine.medical_specialty ,Pediatric Obesity ,Adolescent ,Motivational interviewing ,Psychological intervention ,Healthy lifestyle ,030209 endocrinology & metabolism ,Health Promotion ,Overweight ,Pediatrics ,Childhood obesity ,RJ1-570 ,03 medical and health sciences ,Screen time ,Young Adult ,Study Protocol ,0302 clinical medicine ,Intervention (counseling) ,medicine ,Humans ,030212 general & internal medicine ,Child ,Socioeconomic status ,Exercise ,Schools ,Primary prevention ,business.industry ,Public health ,Low-income population ,Pediatric obesity ,medicine.disease ,Social Class ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Health status disparities ,medicine.symptom ,business - Abstract
Background Childhood obesity represents a global public health crisis: the number of obese children and adolescents (aged 5–19 years) worldwide has risen tenfold in the past four decades. The vast majority of overweight and obese children live in high-income countries, and low socio-economic status (SES) is a significant risk factor. Family Based Interventions (FBI) have demonstrated positive results in preventing obesity, although these results are strongly influenced by SES. Moreover, we still poorly understand how FBI can determine a positive trend in weight status in low-income communities. Therefore, there is an urgent need to define and evaluate innovative and multi-target projects to reduce obesity risk behaviors and health inequalities and the present study aims to present the study protocol of FIVALIN a FBI that pretends to achieve this goal. Methods We will conduct a quasi-experimental design within 60 Community Child Centers (CCC) in Barcelona metropolitan area. Each cluster (CCC) will be assigned by convenience to the intervention and control groups. For the whole study, a total of 810 children aged 8–12 years and 600 parents will be recruited during 3 consecutive editions (1st – 2019/2020; 2nd – 2020/2021; 3rd – 2021/2022) of 10 months each. The action is a regular multicomponent health-promotion intervention targeting children, families, and CCC. All activities are based on the Motivational Interviewing (MI) approach and will focus on promoting good dietary habits, physical activity, appropriate screen time and sleep duration, and psychological well-being. The control group participate in a unique workshop on general awareness of healthy lifestyles for families. We will perform a comparative analysis of the evolution of weight status, healthy lifestyles, and socioeconomic variables, between the intervention and control groups. Discussion There is a need for more evidence on how to target and evaluate holistic interventions in low SES families. Our multi-targeting intervention for obesity prevention tackles risky behaviors that go beyond diet and physical activity (PA). Therefore, future interventions can effectively promote all the behavioral domains that determine trends in the weight status. Trial registration ISRCTN Registry: ISRCRN12682870. Registered 9 July 2020. Retrospectively registered. Protocol version: 30 April 2021, version 5.
- Published
- 2021
67. Additional file 2 of Family-based intervention to prevent childhood obesity among school-age children of low socioeconomic status: study protocol of the FIVALIN project
- Author
-
C. Homs, P. Berruezo, G. Según, L. Estrada, J. De Bont, J. Riera-Romaní, E. Carrillo-Álvarez, H. Schröder, R. Milà, and Gómez, S. F.
- Abstract
Additional file 2. Theoretical models applied in the FIVALIN project by project activities. List of project activities where Theoretical models are applied.
- Published
- 2021
- Full Text
- View/download PDF
68. Additional file 4 of Family-based intervention to prevent childhood obesity among school-age children of low socioeconomic status: study protocol of the FIVALIN project
- Author
-
C. Homs, P. Berruezo, G. Según, L. Estrada, J. De Bont, J. Riera-Romaní, E. Carrillo-Álvarez, H. Schröder, R. Milà, and Gómez, S. F.
- Abstract
Additional file 4. INFORMATION SHEET AND INFORMED CONSENT FIVALIN STUDY.
- Published
- 2021
- Full Text
- View/download PDF
69. Additional file 1 of Family-based intervention to prevent childhood obesity among school-age children of low socioeconomic status: study protocol of the FIVALIN project
- Author
-
C. Homs, P. Berruezo, G. Según, L. Estrada, J. De Bont, J. Riera-Romaní, E. Carrillo-Álvarez, H. Schröder, R. Milà, and Gómez, S. F.
- Subjects
education ,ComputingMilieux_MISCELLANEOUS - Abstract
Additional file 1. Strategies to train new staff and assure consistency of the intervention. List of strategies to ensure intervention consistency and train new staff.
- Published
- 2021
- Full Text
- View/download PDF
70. Additional file 3 of Family-based intervention to prevent childhood obesity among school-age children of low socioeconomic status: study protocol of the FIVALIN project
- Author
-
C. Homs, P. Berruezo, G. Según, L. Estrada, J. De Bont, J. Riera-Romaní, E. Carrillo-Álvarez, H. Schröder, R. Milà, and Gómez, S. F.
- Abstract
Additional file 3. Physical Activity Unified-7 item Screener (PAU-7S). English version of Physical Activity Unified– 7 items Screener (PAU-7S) administered to children.
- Published
- 2021
- Full Text
- View/download PDF
71. Arterial blood stealing as a mechanism of negative BOLD response: From the steady-flow with nonlinear phase separation to a windkessel-based model
- Author
-
Nikolaos M. Tsoukias, Arash Moshkforoush, Alejandro Suarez, Pedro A. Valdés-Hernández, and Jorge J. Riera
- Subjects
Statistics and Probability ,Hemodynamics ,Theft ,Hematocrit ,General Biochemistry, Genetics and Molecular Biology ,Article ,Microcirculation ,medicine ,Blood-oxygen-level dependent ,General Immunology and Microbiology ,medicine.diagnostic_test ,Chemistry ,Applied Mathematics ,Brain ,General Medicine ,Blood flow ,Laser Doppler velocimetry ,Magnetic Resonance Imaging ,Oxygen ,Cerebral blood flow ,Modeling and Simulation ,Cerebrovascular Circulation ,Arterial blood ,General Agricultural and Biological Sciences ,Biological system - Abstract
Blood Oxygen Level Dependent (BOLD) signal indirectly characterizes neuronal activity by measuring hemodynamic and metabolic changes in the nearby microvasculature. A deeper understanding of how localized changes in electrical, metabolic and hemodynamic factors translate into a BOLD signal is crucial for the interpretation of functional brain imaging techniques. While positive BOLD responses (PBR) are widely considered to be linked with neuronal activation, the origins of negative BOLD responses (NBR) have remained largely unknown. As NBRs are sometimes observed in close proximity of regions with PBR, a blood "stealing" effect, i.e., redirection of blood from a passive periphery to the area with high neuronal activity, has been postulated. In this study, we used the Hagen-Poiseuille equation to model hemodynamics in an idealized microvascular network that account for the particulate nature of blood and nonlinearities arising from the red blood cell (RBC) distribution (i.e., the Fahraeus, Fahraeus-Lindqvist and the phase separation effects). Using this detailed model, we evaluate determinants driving this "stealing" effect in a microvascular network with geometric parameters within physiological ranges. Model simulations predict that during localized cerebral blood flow (CBF) increases due to neuronal activation-hyperemic response, blood from surrounding vessels is reallocated towards the activated region. This stealing effect depended on the resistance of the microvasculature and the uneven distribution of RBCs at vessel bifurcations. A parsimonious model consisting of two-connected windkessel regions sharing a supplying artery was proposed to simulate the stealing effect with a minimum number of parameters. Comparison with the detailed model showed that the parsimonious model can reproduce the observed response for hematocrit values within the physiological range for different species. Our novel parsimonious model promise to be of use for statistical inference (top-down analysis) from direct blood flow measurements (e.g., arterial spin labeling and laser Doppler/Speckle flowmetry), and when combined with theoretical models for oxygen extraction/diffusion will help account for some types of NBRs.
- Published
- 2020
72. Patients' contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions
- Author
-
J, Riera-Arnau, L A, Alvarado Aguirre, N, Garcia Doladé, X, Vidal Guitart, A, Figueras, and G, Cereza García
- Subjects
Adult ,Aged, 80 and over ,Male ,Adolescent ,Drug-Related Side Effects and Adverse Reactions ,Emotions ,Infant ,Middle Aged ,Pharmacovigilance ,Young Adult ,Spain ,Child, Preschool ,Adverse Drug Reaction Reporting Systems ,Humans ,Female ,Self Report ,Child ,Aged - Abstract
There are few studies on the personal view retrieved by patients in the spontaneous reports' free-text section of suspected adverse drug reactions.We analysed the suspected adverse drug reactions (ADRs) spontaneous reports sent to the Catalan Centre of Pharmacovigilance between 2013 and 2017. The information provided in the free-text section was classified as (1) temporal sequence, (2) description of symptoms, (3) description of psychological impact, (4) withdrawal effects, (5) alternative causes, and (6) rechallenge. The concordance level between the perceived severity by the reporter and the pharmacovigilance team was assessed by the Kappa index (ƙ). Usual descriptive statistics were used to describe variables.Nationally, 190 spontaneous reports described 383 ADRs, which 28.6% were unknown or poorly known in the literature, and 52.1% were serious. The most frequent ADRs were gastrointestinal (19.3%) and neurological (19.1%), and among the most common 213 suspected medicines, there were those used for nervous system conditions (18.8%). The agreement on the perception of ADRs' severity between citizens and centre's technicians was 'good' (K = 0.62 (0.51-0.72)). An analysis of the free-text section of reports showed that one-quarter of the reports provided useful additional data, like the psychobiosocial impact, which could explain the discrepancy between patients and health professionals in the classification of the severity of some ADRs.Patients' report free-text section provides relevant information, mainly about symptoms description, psychobiosocial impact and feelings. Therefore, it is a section to be enhanced and analysed. These findings should encourage the strengthening of citizens reporting.
- Published
- 2020
73. A Minimal Biophysical Model of Neocortical Pyramidal Cells: Implications for Frontal Cortex Microcircuitry and Field Potential Generation
- Author
-
Amirsaman Sajad, Geoffrey F. Woodman, Beatriz Herrera, Jorge J. Riera, and Jeffrey D. Schall
- Subjects
Male ,0301 basic medicine ,Frontal cortex ,Calcium Channels, L-Type ,Field (physics) ,Models, Neurological ,Biophysics ,Neocortex ,Local field potential ,Electroencephalography ,Macaque ,Sodium Channels ,Minimal model ,03 medical and health sciences ,0302 clinical medicine ,biology.animal ,Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels ,medicine ,Animals ,Computer Simulation ,Calcium Signaling ,Evoked Potentials ,Research Articles ,Ionic Channels ,030304 developmental biology ,Physics ,0303 health sciences ,biology ,medicine.diagnostic_test ,Pyramidal Cells ,General Neuroscience ,Compartment (ship) ,Dendrites ,Current source ,Slow inactivation ,Electrophysiology ,Macaca radiata ,030104 developmental biology ,Frontal lobe ,Nerve Net ,Neuroscience ,Algorithms ,030217 neurology & neurosurgery ,Delayed Rectifier Potassium Channels - Abstract
Ca2+spikes initiated in the distal trunk of layer 5 pyramidal cells (PCs) underlie nonlinear dynamic changes in the gain of cellular response, critical for top-down control of cortical processing. Detailed models with many compartments and dozens of ionic channels can account for this Ca2+spike-dependent gain and associated critical frequency. However, current models do not account for all known Ca2+-dependent features. Previous attempts to include more features have required increasing complexity, limiting their interpretability and utility for studying large population dynamics. We overcome these limitations in a minimal two-compartment biophysical model. In our model, a basal-dendrites/somatic compartment included fast-inactivating Na+and delayed-rectifier K+conductances, while an apical-dendrites/trunk compartment included persistent Na+, hyperpolarization-activated cation (Ih), slow-inactivating K+, muscarinic K+, and Ca2+L-type. The model replicated the Ca2+spike morphology and its critical frequency plus three other defining features of layer 5 PC synaptic integration: linear frequency-current relationships, back-propagation-activated Ca2+spike firing, and a shift in the critical frequency by blocking Ih. Simulating 1000 synchronized layer 5 PCs, we reproduced the current source density patterns evoked by Ca2+spikes and describe resulting medial-frontal EEG on a male macaque monkey. We reproduced changes in the current source density when Ihwas blocked. Thus, a two-compartment model with five crucial ionic currents in the apical dendrites reproduces all features of these neurons. We discuss the utility of this minimal model to study the microcircuitry of agranular areas of the frontal lobe involved in cognitive control and responsible for event-related potentials, such as the error-related negativity.SIGNIFICANCE STATEMENTA minimal model of layer 5 pyramidal cells replicates all known features crucial for distal synaptic integration in these neurons. By redistributing voltage-gated and returning transmembrane currents in the model, we establish a theoretical framework for the investigation of cortical microcircuit contribution to intracranial local field potentials and EEG. This tractable model will enable biophysical evaluation of multiscale electrophysiological signatures and computational investigation of cortical processing.
- Published
- 2020
74. Efficient muscle distribution reflects the positive influence of coenzyme Q10 Phytosome in healthy aging athletes after stressing exercise
- Author
-
J. Riera, Rafael Artuch, A. Codina, Montse Banquells, Giovanna Petrangolini, Franchek Drobnic, Raquel Montero, Stefano Togni, Cristina Jou, Abraham J Paredes-Fuentes, Pietro Allegrini, Antonella Riva, and Joan Carles Domingo
- Subjects
medicine.medical_specialty ,Antioxidant ,Estrès oxidatiu ,medicine.medical_treatment ,Inflammation ,Exercici ,Oxidative phosphorylation ,medicine.disease_cause ,Proinflammatory cytokine ,chemistry.chemical_compound ,Internal medicine ,Medicine ,Exercise ,Coenzyme Q10 ,chemistry.chemical_classification ,Reactive oxygen species ,business.industry ,Muscles ,Músculs ,Bioavailability ,Enzymes ,Endocrinology ,chemistry ,Oxidative stress ,medicine.symptom ,Enzims ,business - Abstract
Coenzyme Q10 (CoQ10) is an ubiquitously-distributed molecule with a key role in mitochondrial efficiency, involving protection against peroxidation induced by reactive oxygen species. In athletes during intense training and strenuous exercise, a reactive oxygen species overproduction occurs and can cause muscular stress and damage: a reduction of those undesired effects would be of benefit. CoQ10 antioxidant properties are described in several clinical studies, but efficacy of CoQ10 supplementation in pre-senescent athletes has not yet been clearly demonstrated. A randomized, intervention-controlled, single-center clinical trial was performed in healthy aging (pre-senescent) runners undergoing exercise training in conditions of high environmental stress. One group used an innovative food-grade CoQ10 phytosome formulation (Ubiqsome) daily for 30 days, while the control group did not take supplementation. Phytosome technique applied to CoQ10 successfully increased CoQ10 bioavailability, as previously demonstrated. CoQ10 levels and oxidative with inflammatory markers were detected in both plasma and muscle. Data obtained highlighted that 500 mg of CoQ10 phytosome (corresponding to 100 mg CoQ10), administered once a day for 30 days significantly improved CoQ10 bioavailability in healthy volunteer aging runners (50-65 years) by increasing both plasmatic and muscular CoQ10 levels, with a reduction of inflammatory cytokines and Malonyl Dialdehyde levels suggesting a protective effect induced by supplementation. The original CoQ10 phytosome formulation results to be of benefit in increasing CoQ10 plasmatic and muscular levels when CoQ10 decrease occurred for oxidative stress conditions, aging or high training.
- Published
- 2020
75. Global injury morbidity and mortality from 1990 to 2017: Results from the global burden of disease study 2017
- Author
-
James, S.L. Castle, C.D. Dingels, Z.V. Fox, J.T. Hamilton, E.B. Liu, Z. Roberts, N.L.S. Sylte, D.O. Henry, N.J. LeGrand, K.E. Abdelalim, A. Abdoli, A. Abdollahpour, I. Abdulkader, R.S. Abedi, A. Abosetugn, A.E. Abushouk, A.I. Adebayo, O.M. Agudelo-Botero, M. Ahmad, T. Ahmed, R. Ahmed, M.B. Aichour, M.T.E. Alahdab, F. Alamene, G.M. Alanezi, F.M. Alebel, A. Alema, N.M. Alghnam, S.A. Al-Hajj, S. Ali, B.A. Ali, S. Alikhani, M. Alinia, C. Alipour, V. Aljunid, S.M. Almasi-Hashiani, A. Almasri, N.A. Altirkawi, K. Amer, Y.S.A. Amini, S. Amit, A.M.L. Andrei, C.L. Ansari-Moghaddam, A. Antonio, C.A.T. Appiah, S.C.Y. Arabloo, J. Arab-Zozani, M. Arefi, Z. Aremu, O. Ariani, F. Arora, A. Asaad, M. Asghari, B. Awoke, N. Quintanilla, B.P.A. Ayano, G. Ayanore, M.A. Azari, S. Azarian, G. Badawi, A. Badiye, A.D. Bagli, E. Baig, A.A. Bairwa, M. Bakhtiari, A. Balachandran, A. Banach, M. Banerjee, S.K. Banik, P.C. Banstola, A. Barker-Collo, S.L. Bärnighausen, T.W. Barrero, L.H. Barzegar, A. Bayati, M. Baye, B.A. Bedi, N. Behzadifar, M. Bekuma, T.T. Belete, H. Benjet, C. Bennett, D.A. Bensenor, I.M. Berhe, K. Bhardwaj, P. Bhat, A.G. Bhattacharyya, K. Bibi, S. Bijani, A. Sayeed, M.S.B. Borges, G. Borzì, A.M. Boufous, S. Brazinova, A. Briko, N.I. Budhathoki, S.S. Car, J. Cárdenas, R. Carvalho, F. Castaldelli-Maia, J.M. Castañeda-Orjuela, C.A. Castelpietra, G. Catalá-López, F. Cerin, E. Chandan, J.S. Chanie, W.F. Chattu, S.K. Chattu, V.K. Chatziralli, I. Chaudhary, N. Cho, D.Y. Chowdhury, M.A.K. Chu, D.-T. Colquhoun, S.M. Constantin, M.-M. Costa, V.M. Damiani, G. Daryani, A. Dávila-Cervantes, C.A. Demeke, F.M. Demis, A.B. Demoz, G.T. Demsie, D.G. Derakhshani, A. Deribe, K. Desai, R. Nasab, M.D. Dias da Silva, D. Forooshani, Z.S.D. Doyle, K.E. Driscoll, T.R. Dubljanin, E. Adema, B.D. Eagan, A.W. Eftekhari, A. Ehsani-Chimeh, E. El Sayed Zaki, M. Elemineh, D.A. El-Jaafary, S.I. El-Khatib, Z. Ellingsen, C.L. Emamian, M.H. Endalew, D.A. Eskandarieh, S. Faris, P.S. Faro, A. Farzadfar, F. Fatahi, Y. Fekadu, W. Ferede, T.Y. Fereshtehnejad, S.-M. Fernandes, E. Ferrara, P. Feyissa, G.T. Filip, I. Fischer, F. Folayan, M.O. Foroutan, M. Francis, J.M. Franklin, R.C. Fukumoto, T. Geberemariyam, B.S. Gebre, A.K. Gebremedhin, K.B. Gebremeskel, G.G. Gebremichael, B. Gedefaw, G.A. Geta, B. Ghafourifard, M. Ghamari, F. Ghashghaee, A. Gholamian, A. Gill, T.K. Goulart, A.C. Grada, A. Grivna, M. Gubari, M.I.M. Guimarães, R.A. Guo, Y. Gupta, G. Haagsma, J.A. Hafezi-Nejad, N. Bidgoli, H.H. Hall, B.J. Hamadeh, R.R. Hamidi, S. Haro, J.M. Hasan, M.M. Hasanzadeh, A. Hassanipour, S. Hassankhani, H. Hassen, H.Y. Havmoeller, R. Hayat, K. Hendrie, D. Heydarpour, F. Híjar, M. Ho, H.C. Hoang, C.L. Hole, M.K. Holla, R. Hossain, N. Hosseinzadeh, M. Hostiuc, S. Hu, G. Ibitoye, S.E. Ilesanmi, O.S. Ilic, I. Ilic, M.D. Inbaraj, L.R. Indriasih, E. Irvani, S.S.N. Islam, S.M.S. Mofizul Islam, M. Ivers, R.Q. Jacobsen, K.H. Jahani, M.A. Jahanmehr, N. Jakovljevic, M. Jalilian, F. Jayaraman, S. Jayatilleke, A.U. Jha, R.P. John-Akinola, Y.O. Jonas, J.B. Joseph, N. Joukar, F. Jozwiak, J.J. Jungari, S.B. Jürisson, M. Kabir, A. Kadel, R. Kahsay, A. Kalankesh, L.R. Kalhor, R. Kamil, T.A. Kanchan, T. Kapoor, N. Karami, M. Kasaeian, A. Kassaye, H.G. Kavetskyy, T. Kebede, H.K. Keiyoro, P.N. Kelbore, A.G. Kelkay, B. Khader, Y.S. Khafaie, M.A. Khalid, N. Khalil, I.A. Khalilov, R. Khammarnia, M. Khan, E.A. Khan, M. Khanna, T. Khazaie, H. Shadmani, F.K. Khundkar, R. Kiirithio, D.N. Kim, Y.-E. Kim, D. Kim, Y.J. Kisa, A. Kisa, S. Komaki, H. Kondlahalli, S.K.M. Korshunov, V.A. Koyanagi, A. Kraemer, M.U.G. Krishan, K. Bicer, B.K. Kugbey, N. Kumar, V. Kumar, N. Anil Kumar, G. Kumar, M. Kumaresh, G. Kurmi, O.P. Kuti, O. Vecchia, C.L. Lami, F.H. Lamichhane, P. Lang, J.J. Lansingh, V.C. Laryea, D.O. Lasrado, S. Latifi, A. Lauriola, P. Leasher, J.L. Lee, S.W.H. Lenjebo, T.L. Levi, M. Li, S. Linn, S. Liu, X. Lopez, A.D. Lotufo, P.A. Lunevicius, R. Lyons, R.A. Madadin, M. El Razek, M.M.A. Mahotra, N.B. Majdan, M. Majeed, A. Malagon-Rojas, J.N. Maled, V. Malekzadeh, R. Malta, D.C. Manafi, N. Manafi, A. Manda, A.-L. Manjunatha, N. Mansour-Ghanaei, F. Mansouri, B. Mansournia, M.A. Maravilla, J.C. March, L.M. Mason-Jones, A.J. Masoumi, S.Z. Massenburg, B.B. Maulik, P.K. Meles, G.G. Melese, A. Melketsedik, Z.A. Memiah, P.T.N. Mendoza, W. Menezes, R.G. Mengesha, M.B. Mengesha, M.M. Meretoja, T.J. Meretoja, A. Merie, H.E. Mestrovic, T. Miazgowski, B. Miazgowski, T. Miller, T.R. Mini, G.K. Mirica, A. Mirrakhimov, E.M. Mirzaei-Alavijeh, M. Mithra, P. Moazen, B. Moghadaszadeh, M. Mohamadi, E. Mohammad, Y. Mohammad, K.A. Darwesh, A.M. Mezerji, N.M.G. Mohammadian-Hafshejani, A. Mohammadoo-Khorasani, M. Mohammadpourhodki, R. Mohammed, S. Mohammed, J.A. Mohebi, F. Molokhia, M. Monasta, L. Moodley, Y. Moosazadeh, M. Moradi, M. Moradi, G. Moradi-Lakeh, M. Moradpour, F. Morawska, L. Velásquez, I.M. Morisaki, N. Morrison, S.D. Mossie, T.B. Muluneh, A.G. Murthy, S. Musa, K.I. Mustafa, G. Nabhan, A.F. Nagarajan, A.J. Naik, G. Naimzada, M.D. Najafi, F. Nangia, V. Nascimento, B.R. Naserbakht, M. Nayak, V. Ndwandwe, D.E. Negoi, I. Ngunjiri, J.W. Nguyen, C.T. Nguyen, H.L.T. Nikbakhsh, R. Ningrum, D.N.A. Nnaji, C.A. Nyasulu, P.S. Ogbo, F.A. Oghenetega, O.B. Oh, I.-H. Okunga, E.W. Olagunju, A.T. Olagunju, T.O. Bali, A.O. Onwujekwe, O.E. Asante, K.O. Orpana, H.M. Ota, E. Otstavnov, N. Otstavnov, S.S. Mahesh, P.A. Padubidri, J.R. Pakhale, S. Pakshir, K. Panda-Jonas, S. Park, E.-K. Patel, S.K. Pathak, A. Pati, S. Patton, G.C. Paulos, K. Peden, A.E. Pepito, V.C.F. Pereira, J. Pham, H.Q. Phillips, M.R. Pinheiro, M. Polibin, R.V. Polinder, S. Poustchi, H. Prakash, S. Pribadi, D.R.A. Puri, P. Syed, Z.Q. Rabiee, M. Rabiee, N. Radfar, A. Rafay, A. Rafiee, A. Rafiei, A. Rahim, F. Rahimi, S. Rahimi-Movaghar, V. Rahman, M.A. Rajabpour-Sanati, A. Rajati, F. Rakovac, I. Ranganathan, K. Rao, S.J. Rashedi, V. Rastogi, P. Rathi, P. Rawaf, S. Rawal, L. Rawassizadeh, R. Renjith, V. Renzaho, A.M.N. Resnikoff, S. Rezapour, A. Ribeiro, A.I. Rickard, J. González, C.M.R. Ronfani, L. Roshandel, G. Saad, A.M. Sabde, Y.D. Sabour, S. Saddik, B. Safari, S. Safari-Faramani, R. Safarpour, H. Safdarian, M. Mohammad Sajadi, S. Salamati, P. Salehi, F. Zahabi, S.S. Rashad Salem, M.R. Salem, H. Salman, O. Salz, I. Samy, A.M. Sanabria, J. Riera, L.S. Santric Milicevic, M.M. Sarker, A.R. Sarveazad, A. Sathian, B. Sawhney, M. Sawyer, S.M. Saxena, S. Sayyah, M. Schwebel, D.C. Seedat, S. Senthilkumaran, S. Sepanlou, S.G. Seyedmousavi, S. Sha, F. Shaahmadi, F. Shahabi, S. Shaikh, M.A. Shams-Beyranvand, M. Shamsizadeh, M. Sharif-Alhoseini, M. Sharifi, H. Sheikh, A. Shigematsu, M. Shin, J.I. Shiri, R. Siabani, S. Sigfusdottir, I.D. Singh, P.K. Singh, J.A. Sinha, D.N. Smarandache, C.-G. Smith, E.U.R. Soheili, A. Soleymani, B. Soltanian, A.R. Soriano, J.B. Sorrie, M.B. Soyiri, I.N. Stein, D.J. Stokes, M.A. Mu'awiyyah, B.S. Suleria, H.A.R. Sykes, B.L. Tabarés-Seisdedos, R. Tabb, K.M. Taddele, B.W. Tadesse, D.B. Tamiru, A.T. Tarigan, I.U. Tefera, Y.M. Tehrani-Banihashemi, A. Tekle, M.G. Tekulu, G.H. Tesema, A.K. Tesfay, B.E. Thapar, R. Tilahune, A.B. Tlaye, K.G. Tohidinik, H.R. Topor-Madry, R. Tran, B.X. Tran, K.B. Tripathy, J.P. Tsai, A.C. Car, L.T. Ullah, S. Ullah, I. Umar, M. Unnikrishnan, B. Upadhyay, E. Uthman, O.A. Valdez, P.R. Vasankari, T.J. Venketasubramanian, N. Violante, F.S. Vlassov, V. Waheed, Y. Weldesamuel, G.T. Werdecker, A. Wiangkham, T. Wolde, H.F. Woldeyes, D.H. Wondafrash, D.Z. Wondmeneh, T.G. Wondmieneh, A.B. Wu, A.-M. Yadav, R. Yadollahpour, A. Yano, Y. Yaya, S. Yazdi-Feyzabadi, V. Yip, P. Yisma, E. Yonemoto, N. Yoon, S.-J. Youm, Y. Younis, M.Z. Yousefi, Z. Yu, Y. Yu, C. Yusefzadeh, H. Moghadam, T.Z. Zaidi, Z. Zaman, S.B. Zamani, M. Zamanian, M. Zandian, H. Zarei, A. Zare, F. Zhang, Z.-J. Zhang, Y. Zodpey, S. Dandona, L. Dandona, R. Degenhardt, L. Dharmaratne, S.D. Hay, S.I. Mokdad, A.H. Reiner, R.C., Jr. Sartorius, B. Vos, T.
- Abstract
Background Past research in population health trends has shown that injuries form a substantial burden of population health loss. Regular updates to injury burden assessments are critical. We report Global Burden of Disease (GBD) 2017 Study estimates on morbidity and mortality for all injuries. methods We reviewed results for injuries from the GBD 2017 study. GBD 2017 measured injury-specific mortality and years of life lost (YLLs) using the Cause of Death Ensemble model. To measure non-fatal injuries, GBD 2017 modelled injury-specific incidence and converted this to prevalence and years lived with disability (YLDs). YLLs and YLDs were summed to calculate disability-adjusted life years (DALYs). Findings In 1990, there were 4 260 493 (4 085 700 to 4 396 138) injury deaths, which increased to 4 484 722 (4 332 010 to 4 585 554) deaths in 2017, while age-standardised mortality decreased from 1079 (1073 to 1086) to 738 (730 to 745) per 100 000. In 1990, there were 354 064 302 (95% uncertainty interval: 338 174 876 to 371 610 802) new cases of injury globally, which increased to 520 710 288 (493 430 247 to 547 988 635) new cases in 2017. During this time, age-standardised incidence decreased non-significantly from 6824 (6534 to 7147) to 6763 (6412 to 7118) per 100 000. Between 1990 and 2017, age-standardised DALYs decreased from 4947 (4655 to 5233) per 100 000 to 3267 (3058 to 3505). Interpretation Injuries are an important cause of health loss globally, though mortality has declined between 1990 and 2017. Future research in injury burden should focus on prevention in high-burden populations, improving data collection and ensuring access to medical care. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.
- Published
- 2020
76. Skin manifestations in COVID-19: prevalence and relationship with disease severity
- Author
-
J. Riera-Monroig, Alex Almuedo-Riera, Priscila Giavedoni, Ignasi Marti-Marti, Cristina Andreu-Febrer, Constanza Riquelme-Mc Loughlin, Sebastian Podlipnik, Jose Muñoz, Ramon Pigem, Daniel Morgado-Carrasco, Pilar Iranzo, Irene Fuertes de Vega, Daniel Rizo-Potau, José M. Mascaró, Cristina Carrera, Adriana García-Herrera, Judit Sanz-Beltran, Susana Puig, Andrea Combalia, Francesc Alamon-Reig, Llucia Alos, Juan M. Pericàs, Agustí Toll-Abelló, Laura Serra-García, and Xavier Bosch-Amate
- Subjects
medicine.medical_specialty ,coronavirus ,skin lesions ,lcsh:Medicine ,Disease ,Article ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,medicine ,030212 general & internal medicine ,Direct fluorescent antibody ,Livedo reticularis ,Skin ,Lung ,business.industry ,pandemic ,lcsh:R ,COVID-19 ,Histology ,Pell ,General Medicine ,Dermatology ,medicine.anatomical_structure ,Cohort ,histopathology ,Immunohistochemistry ,Histopathology ,medicine.symptom ,business ,chilblain - Abstract
Background: Data on the clinical patterns and histopathology of SARS-CoV-2 related skin lesions, as well as on their relationship with the severity of COVID-19 are limited. Methods and Materials: Retrospective analysis of a prospectively collected cohort of patients with SARS-CoV-2 infection in a teaching hospital in Barcelona, Spain, from 1 April to 1 May 2020. Clinical, microbiological and therapeutic characteristics, clinicopathological patterns of skin lesions, and direct immunofluorescence and immunohistochemical findings in skin biopsies were analyzed. Results: Fifty-eight out of the 2761 patients (2.1%) either consulting to the emergency room or admitted to the hospital for COVID-19 suspicion during the study period presented COVID-19 related skin lesions. Cutaneous lesions could be categorized into six patterns represented by the acronym &ldquo, GROUCH&rdquo, Generalized maculo-papular (20.7%), Grover&rsquo, s disease and other papulo-vesicular eruptions (13.8%), livedo Reticularis (6.9%), Other eruptions (22.4%), Urticarial (6.9%), and CHilblain-like (29.3%). Skin biopsies were performed in 72.4%, including direct immunofluorescence in 71.4% and immunohistochemistry in 28.6%. Patients with chilblain-like lesions exhibited a characteristic histology and were significantly younger and presented lower rates of systemic symptoms, radiological lung infiltrates and analytical abnormalities, and hospital and ICU admission compared to the rest of patients. Conclusion: Cutaneous lesions in patients with COVID-19 appear to be relatively rare and varied. Patients with chilblain-like lesions have a characteristic clinicopathological pattern and a less severe presentation of COVID-19.
- Published
- 2020
77. Estimating global injuries morbidity and mortality: Methods and data used in the Global Burden of Disease 2017 study
- Author
-
James, S.L. Castle, C.D. Dingels, Z.V. Fox, J.T. Hamilton, E.B. Liu, Z. Roberts, N.L.S. Sylte, D.O. Bertolacci, G.J. Cunningham, M. Henry, N.J. Legrand, K.E. Abdelalim, A. Abdollahpour, I. Abdulkader, R.S. Abedi, A. Abegaz, K.H. Abosetugn, A.E. Abushouk, A.I. Adebayo, O.M. Adsuar, J.C. Advani, S.M. Agudelo-Botero, M. Ahmad, T. Ahmed, M.B. Ahmed, R. Aichour, M.T.E. Alahdab, F. Alanezi, F.M. Alema, N.M. Alemu, B.W. Alghnam, S.A. Ali, B.A. Ali, S. Alinia, C. Alipour, V. Aljunid, S.M. Almasi-Hashiani, A. Almasri, N.A. Altirkawi, K. Amer, Y.S.A. Andrei, C.L. Ansari-Moghaddam, A. Antonio, C.A.T. Anvari, D. Appiah, S.C.Y. Arabloo, J. Arab-Zozani, M. Arefi, Z. Aremu, O. Ariani, F. Arora, A. Asaad, M. Quintanilla, B.P.A. Ayano, G. Ayanore, M.A. Azarian, G. Badawi, A. Badiye, A.D. Baig, A.A. Bairwa, M. Bakhtiari, A. Balachandran, A. Banach, M. Banerjee, S.K. Banik, P.C. Banstola, A. Barker-Collo, S.L. Bärnighausen, T.W. Barzegar, A. Bayati, M. Bazargan-Hejazi, S. Bedi, N. Behzadifar, M. Belete, H. Bennett, D.A. Bensenor, I.M. Berhe, K. Bhagavathula, A.S. Bhardwaj, P. Bhat, A.G. Bhattacharyya, K. Bhutta, Z.A. Bibi, S. Bijani, A. Boloor, A. Borges, G. Borschmann, R. Borzì, A.M. Boufous, S. Braithwaite, D. Briko, N.I. Brugha, T. Budhathoki, S.S. Car, J. Cárdenas, R. Carvalho, F. Castaldelli-Maia, J.M. Castañeda-Orjuela, C.A. Castelpietra, G. Catalá-López, F. Cerin, E. Chandan, J.S. Chapman, J.R. Chattu, V.K. Chattu, S.K. Chatziralli, I. Chaudhary, N. Cho, D.Y. Choi, J.-Y.J. Chowdhury, M.A.K. Christopher, D.J. Chu, D.-T. Cicuttini, F.M. Coelho, J.M. Costa, V.M. Dahlawi, S.M.A. Daryani, A. Dávila-Cervantes, C.A. De Leo, D. Demeke, F.M. Demoz, G.T. Demsie, D.G. Deribe, K. Desai, R. Nasab, M.D. Da Silva, D.D. Forooshani, Z.S.D. Do, H.T. Doyle, K.E. Driscoll, T.R. Dubljanin, E. Adema, B.D. Eagan, A.W. Elemineh, D.A. El-Jaafary, S.I. El-Khatib, Z. Ellingsen, C.L. El Sayedzaki, M. Eskandarieh, S. Eyawo, O. Faris, P.S. Faro, A. Farzadfar, F. Fereshtehnejad, S.-M. Fernandes, E. Ferrara, P. Fischer, F. Folayan, M.O. Fomenkov, A.A. Foroutan, M. Francis, J.M. Franklin, R.C. Fukumoto, T. Geberemariyam, B.S. Gebremariam, H. Gebremedhin, K.B. Gebremeskel, L.G. Gebremeskel, G.G. Gebremichael, B. Gedefaw, G.A. Geta, B. Getenet, A.B. Ghafourifard, M. Ghamari, F. Gheshlagh, R.G. Gholamian, A. Gilani, S.A. Gill, T.K. Goudarzian, A.H. Goulart, A.C. Grada, A. Grivna, M. Guimarães, R.A. Guo, Y. Gupta, G. Haagsma, J.A. Hall, B.J. Hamadeh, R.R. Hamidi, S. Handiso, D.W. Haro, J.M. Hasanzadeh, A. Hassan, S. Hassanipour, S. Hassankhani, H. Hassen, H.Y. Havmoeller, R. Hendrie, D. Heydarpour, F. Híjar, M. Ho, H.C. Hoang, C.L. Hole, M.K. Holla, R. Hossain, N. Hosseinzadeh, M. Hostiuc, S. Hu, G. Ibitoye, S.E. Ilesanmi, O.S. Inbaraj, L.R. Irvani, S.S.N. Islam, M.M. Islam, S.M.S. Ivers, R.Q. Jahani, M.A. Jakovljevic, M. Jalilian, F. Jayaraman, S. Jayatilleke, A.U. Jha, R.P. John-Akinola, Y.O. Jonas, J.B. Jones, K.M. Joseph, N. Joukar, F. Jozwiak, J.J. Jungari, S.B. Jürisson, M. Kabir, A. Kahsay, A. Kalankesh, L.R. Kalhor, R. Kamil, T.A. Kanchan, T. Kapoor, N. Karami, M. Kasaeian, A. Kassaye, H.G. Kavetskyy, T. Kayode, G.A. Keiyoro, P.N. Kelbore, A.G. Khader, Y.S. Khafaie, M.A. Khalid, N. Khalil, I.A. Khalilov, R. Khan, M. Khan, E.A. Khan, J. Khanna, T. Khazaei, S. Khazaie, H. Khundkar, R. Kiirithio, D.N. Kim, Y.-E. Kim, Y.J. Kim, D. Kisa, S. Kisa, A. Komaki, H. Kondlahalli, S.K.M. Koolivand, A. Korshunov, V.A. Koyanagi, A. Kraemer, M.U.G. Krishan, K. Defo, B.K. Bicer, B.K. Kugbey, N. Kumar, N. Kumar, M. Kumar, V. Kumar, N. Kumaresh, G. Lami, F.H. Lansingh, V.C. Lasrado, S. Latifi, A. Lauriola, P. Vecchia, C.L. Leasher, J.L. Lee, S.W.H. Li, S. Liu, X. Lopez, A.D. Lotufo, P.A. Lyons, R.A. Machado, D.B. Madadin, M. Abd El Razek, M.M. Mahotra, N.B. Majdan, M. Majeed, A. Maled, V. Malta, D.C. Manafi, N. Manafi, A. Manda, A.-L. Manjunatha, N. Mansour-Ghanaei, F. Mansournia, M.A. Maravilla, J.C. Mason-Jones, A.J. Masoumi, S.Z. Massenburg, B.B. Maulik, P.K. Mehndiratta, M.M. Melketsedik, Z.A. Memiah, P.T.N. Mendoza, W. Menezes, R.G. Mengesha, M.M. Meretoja, T.J. Meretoja, A. Merie, H.E. Mestrovic, T. Miazgowski, B. Miazgowski, T. Miller, T.R. Mini, G.K. Mirica, A. Mirrakhimov, E.M. Mirzaei-Alavijeh, M. Mithra, P. Moazen, B. Moghadaszadeh, M. Mohamadi, E. Mohammad, Y. Darwesh, A.M. Mohammadian-Hafshejani, A. Mohammadpourhodki, R. Mohammed, S. Mohammed, J.A. Mohebi, F. Bandpei, M.A.M. Molokhia, M. Monasta, L. Moodley, Y. Moradi, M. Moradi, G. Moradi-Lakeh, M. Moradzadeh, R. Morawska, L. Velásquez, I.M. Morrison, S.D. Mossie, T.B. Muluneh, A.G. Musa, K.I. Mustafa, G. Naderi, M. Nagarajan, A.J. Naik, G. Naimzada, M.D. Najaf, F. Nangia, V. Nascimento, B.R. Naserbakht, M. Nayak, V. Nazari, J. Ndwandwe, D.E. Negoi, I. Ngunjiri, J.W. Nguyen, T.H. Nguyen, C.T. Nguyen, D.N. Nguyen, H.L.T. Nikbakhsh, R. Ningrum, D.N.A. Nnaji, C.A. Ofori-Asenso, R. Ogbo, F.A. Oghenetega, O.B. Oh, I.-H. Olagunju, A.T. Olagunju, T.O. Bali, A.O. Onwujekwe, O.E. Orpana, H.M. Ota, E. Otstavnov, N. Otstavnov, S.S. Mahesh, A.P. Padubidri, J.R. Pakhale, S. Pakshir, K. Panda-Jonas, S. Park, E.-K. Patel, S.K. Pathak, A. Pati, S. Paulos, K. Peden, A.E. Pepito, V.C.F. Pereira, J. Phillips, M.R. Polibin, R.V. Polinder, S. Pourmalek, F. Pourshams, A. Poustchi, H. Prakash, S. Pribadi, D.R.A. Puri, P. Syed, Z.Q. Rabiee, N. Rabiee, M. Radfar, A. Rafay, A. Rafee, A. Rafei, A. Rahim, F. Rahimi, S. Rahman, M.A. Rajabpour-Sanati, A. Rajati, F. Rakovac, I. Rao, S.J. Rashedi, V. Rastogi, P. Rathi, P. Rawaf, S. Rawal, L. Rawassizadeh, R. Renjith, V. Resnikoff, S. Rezapour, A. Ribeiro, A.I. Rickard, J. González, C.M.R. Roever, L. Ronfani, L. Roshandel, G. Saddik, B. Safarpour, H. Safdarian, M. Sajadi, S.M. Salamati, P. Salem, M.R.R. Salem, H. Salz, I. Samy, A.M. Sanabria, J. Riera, L.S. Milicevic, M.M.S. Sarker, A.R. Sarveazad, A. Sathian, B. Sawhney, M. Sayyah, M. Schwebel, D.C. Seedat, S. Senthilkumaran, S. Seyedmousavi, S. Sha, F. Shaahmadi, F. Shahabi, S. Shaikh, M.A. Shams-Beyranvand, M. Sheikh, A. Shigematsu, M. Shin, J.I. Shiri, R. Siabani, S. Sigfusdottir, I.D. Singh, J.A. Singh, P.K. Sinha, D.N. Soheili, A. Soriano, J.B. Sorrie, M.B. Soyiri, I.N. Stokes, M.A. Sufiyan, M.B. Sykes, B.L. Tabarés-Seisdedos, R. Tabb, K.M. Taddele, B.W. Tefera, Y.M. Tehrani-Banihashemi, A. Tekulu, G.H. Tesema, A.K.T. Tesfay, B.E. Thapar, R. Titova, M.V. Tlaye, K.G. Tohidinik, H.R. Topor-Madry, R. Tran, K.B. Tran, B.X. Tripathy, J.P. Tsai, A.C. Tsatsakis, A. Car, L.T. Ullah, I. Ullah, S. Unnikrishnan, B. Upadhyay, E. Uthman, O.A. Valdez, P.R. Vasankari, T.J. Veisani, Y. Venketasubramanian, N. Violante, F.S. Vlassov, V. Waheed, Y. Wang, Y.-P. Wiangkham, T. Wolde, H.F. Woldeyes, D.H. Wondmeneh, T.G. Wondmieneh, A.B. Wu, A.-M. Wyper, G.M.A. Yadav, R. Yadollahpour, A. Yano, Y. Yaya, S. Yazdi-Feyzabadi, V. Ye, P. Yip, P. Yisma, E. Yonemoto, N. Yoon, S.-J. Youm, Y. Younis, M.Z. Yousef, Z. Yu, C. Yu, Y. Moghadam, T.Z. Zaidi, Z. Zaman, S.B. Zamani, M. Zandian, H. Zarei, F. Zhang, Z.-J. Zhang, Y. Ziapour, A. Zodpey, S. Dandona, R. Dharmaratne, S.D. Hay, S.I. Mokdad, A.H. Pigott, D.M. Reiner, R.C. Vos, T.
- Abstract
Background: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. Methods: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. Results: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. Conclusions: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC B Y. Published by BMJ.
- Published
- 2020
78. waveCSD: A method for estimating transmembrane currents originated from propagating neuronal activity in the neocortex: Application to study cortical spreading depression
- Author
-
Jorge J. Riera, Arash Moshkforoush, Pedro A. Valdés-Hernández, Yoichiro Mori, and Daniel E. Rivera-Espada
- Subjects
0301 basic medicine ,Wave propagation ,Neocortex ,Local field potential ,Alpha wave ,Models, Biological ,Article ,Membrane Potentials ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Animals ,Premovement neuronal activity ,Computer Simulation ,Neurons ,Physics ,General Neuroscience ,Cortical Spreading Depression ,Rats ,Microelectrode ,030104 developmental biology ,medicine.anatomical_structure ,Cortical spreading depression ,Biological system ,030217 neurology & neurosurgery ,Noise (radio) - Abstract
Background Recent years have witnessed an upsurge in the development of methods for estimating current source densities (CSDs) in the neocortical tissue from their recorded local field potential (LFP) reflections using microelectrode arrays. Among these, methods utilizing linear arrays work under the assumption that CSDs vary as a function of cortical depth; whereas they are constant in the tangential direction, infinitely or in a confined cylinder. This assumption is violated in the analysis of neuronal activity propagating along the neocortical sheet, e.g. propagation of alpha waves or cortical spreading depression. New method Here, we developed a novel mathematical method (waveCSD) for CSD analysis of LFPs associated with a planar wave of neocortical neuronal activity propagating at a constant velocity towards a linear probe. Results Results show that the algorithm is robust to the presence of noise in LFP data and uncertainties in knowledge of propagation velocity. Also, results show high level of accuracy of the method in a wide range of electrode resolutions. Using in vivo experimental recordings from the rat neocortex, we employed waveCSD to characterize transmembrane currents associated with cortical spreading depressions. Comparison with existing method(s) Simulation results indicate that waveCSD has a significantly higher reconstruction accuracy compared to the widely-used inverse CSD method (iCSD), and the regularized kernel CSD method (kCSD), in the analysis of CSDs originating from propagating neuronal activity. Conclusions The waveCSD method provides a theoretical platform for estimation of transmembrane currents from their LFPs in experimental paradigms involving wave propagation.
- Published
- 2018
79. P57 Collaborative advance care planning: improving palliative care by structured communications about matters of life and death – the study protocol
- Author
-
Nico Leppin, Nina Timmesfeld, Katharina Nagelschmidt, P Von Blanckenburg, Martin Koch, J Koch, and J Riera-Knorrenschild
- Subjects
Advance care planning ,medicine.medical_specialty ,Palliative care ,business.industry ,media_common.quotation_subject ,humanities ,law.invention ,Distress ,Denial ,Quality of life (healthcare) ,Randomized controlled trial ,law ,Intervention (counseling) ,Family medicine ,Clinical endpoint ,Medicine ,business ,media_common - Abstract
Background Implementation of advance care planning (ACP) is proceeding in the western world and often recognised as a sufficient approach to ensure patients’ wishes for end of life (EoL) care. There is evidence that patient related outcomes are improved. However, information about the impact of ACP on quality of life (QoL) in palliative cancer patients is missing. Methods This randomised controlled trial investigates the efficacy and effectiveness of a collaborative ACP (cACP) intervention in palliative cancer patients and their care givers by comparing three groups: 1. cACP-Intervention; 2. Supportive intervention 3. Treatment as usual. The cACP-intervention consists of four sessions (two with the patient alone, one with the care giver alone, one together) that address potential barriers to discuss end of life issues (e.g. negative expectations concerning EoL issues and ACP) and two regular ACP sessions. Primary endpoint is the patient health-related QoL (FACIT-PAL). Secondary endpoints are general QoL; distress; acceptance; depressiveness; evaluation of the intervention; care-givers: heath-related and general QoL. Patients’ QoL is evaluated every second month for one year. In the event of the patients death, care-givers are asked to answer questions about concordance of advance care planning with actual care and the patients quality of dying. Results Until 11/18, 75 patients have been randomized, 13 patients finished the intervention, 21 patients died, denial rate is at approx. 55%. Conclusion This study tries to implement ACP in a palliative cancer setting in Germany. The efficacy and effectiveness of a novel collaborative ACP intervention are evaluated.
- Published
- 2019
80. OP16 Let’s talk about death: gender effects in cancer patient’s preferences for end-of-life
- Author
-
P Von Blanckenburg, M Hoffmann, J Koch, J Riera-Knorrenschild, Winfried Rief, and Yvonne Nestoriuc
- Subjects
Nursing care ,Aggressive care ,Nursing ,medicine ,Cancer ,Psychology ,medicine.disease ,humanities - Abstract
Background Males receive more aggressive care near death. End-of-life (EOL) conversations can protect from aggressive care near death and support more consistent EOL care. Therefore, information about gender effects on engagement in and realization of EOL conversations are needed. Methods In a cross-sectional study 186 cancer patients from an university and rehab hospital were asked about their preferences for EOL discussions using a semi-structured interview, focusing on a) the importance of six different EOL issues (medical and nursing care, organizational, emotional, social and spiritual/religious aspects), b) the desired time point, c) mode of discussion initiation. Results The importance of EOL topics differ significantly by issue (p=.002, η2=.02) and gender (p Conclusion Because of distinct gender differences for engagement in and realization of EOL conversations a gender sensitive approach is recommended. Independent of gender, the tendency of patients to talk late about EOL issues should be considered to reduce the risk of delayed or neglected EOL conversations. Therefore, a two-step approach of end-of-life conversations is suggested.
- Published
- 2019
81. Violaceous patch in the leg of a tourist
- Author
-
Constanza Riquelme-Mc Loughlin, Pilar Iranzo, and J. Riera-Monroig
- Subjects
Leg ,Humans - Published
- 2019
82. Symposium Title: Areal, Laminar, and Columnar Origins of Event-Related EEG in Granular and Agranular Cortex of Rats, Monkeys, and Humans
- Author
-
Jorge J. Riera
- Subjects
Neuropsychology and Physiological Psychology ,medicine.anatomical_structure ,medicine.diagnostic_test ,Physiology (medical) ,General Neuroscience ,Event (relativity) ,Cortex (anatomy) ,medicine ,Laminar flow ,Biology ,Electroencephalography ,Neuroscience - Published
- 2021
83. 1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK
- Author
-
Claus Bolling, V. Heuer, G.M. Haag, Lisa Waberer, M. Schenk, R.D. Hofheinz, Natsumi Irahara, Timo Gaiser, Albrecht Kretzschmar, Nils Homann, Peter C. Thuss-Patience, T.O. Götze, J. Riera Knorrenschild, U. Lindig, Eray Goekkurt, S-E. Al-Batran, Sylvie Lorenzen, Alexander Rheinhard Siebenhuener, C. Kopp, and Claudia Pauligk
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Microsatellite instability ,Hematology ,Perioperative ,medicine.disease ,Atezolizumab ,Internal medicine ,medicine ,Adenocarcinoma ,In patient ,business ,Pathological - Published
- 2021
84. LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)
- Author
-
U. Lindig, Daniel Pink, J. Riera Knorrenschild, Lutz Jacobasch, Stefan Kubicka, Thomas J. Ettrich, Anke Reinacher-Schick, Joseph Tintelnot, Eray Goekkurt, S. Hegewisch Becker, M. Sinn, S. Lorenzen, Peter C. Thuss-Patience, S-E. Al-Batran, Mascha Binder, Lisa Paschold, A. Kretzschmar, Alexander Stein, and Axel Hinke
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Locally advanced ,Ipilimumab ,Hematology ,medicine.disease ,FOLFOX ,Trastuzumab ,Internal medicine ,medicine ,Adenocarcinoma ,Nivolumab ,business ,medicine.drug - Published
- 2021
85. Eritema necrolítico migratorio asociado a glucagonoma
- Author
-
Xavier Bosch-Amate, Pilar Iranzo Fernández, and J. Riera-Monroig
- Subjects
medicine.medical_specialty ,business.industry ,Medicine ,General Medicine ,business ,Dermatology - Published
- 2020
86. Mácula eritemato-violácea en la pierna de una turista
- Author
-
J. Riera-Monroig, Constanza Riquelme-Mc Loughlin, and Pilar Iranzo
- Subjects
Microbiology (medical) - Published
- 2020
87. Placa violácea ulcerada en un paciente inmunosuprimido. Diagnóstico y comentario
- Author
-
Daniel Morgado-Carrasco, Priscila Giavedoni, and J. Riera-Monroig
- Subjects
Dermatology - Published
- 2020
88. Placa violácea ulcerada en un paciente inmunosuprimido
- Author
-
Priscila Giavedoni, Daniel Morgado-Carrasco, and J. Riera-Monroig
- Subjects
Dermatology - Published
- 2020
89. Respuesta a secukinumab tras fracaso terapéutico con ustekinumab en seis pacientes con psoriasis en placas
- Author
-
Xavier Fustà-Novell, Daniel Morgado-Carrasco, M. Alsina Gibert, and J. Riera-Monroig
- Subjects
business.industry ,Medicine ,General Medicine ,business - Published
- 2018
90. Response to Secukinumab after Treatment Failure with Ustekinumab in 6 Patients with Plaque Psoriasis
- Author
-
M. Alsina Gibert, Daniel Morgado-Carrasco, Xavier Fustà-Novell, and J. Riera-Monroig
- Subjects
Plaque psoriasis ,medicine.medical_specialty ,Histology ,business.industry ,Ustekinumab ,medicine ,Secukinumab ,Dermatology ,business ,After treatment ,Pathology and Forensic Medicine ,medicine.drug - Published
- 2018
91. OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry
- Author
-
A J Lucendo, M Charro, P Nos, P Romero, S Khorrami, L Ramos, J Panes, D Busquets, A Rodríguez-Pescador, Carlos Taxonera, C Muñoz Vilafranca, O García-Bosch, Olga Merino, A Rodríguez, M Mínguez, M Mañosa, À Abad, Y Ber, P Almela, X. Calvet, M D Martín Arranz, A López Sanromán, M Cimavilla, Jordina Llaó, Montserrat Rivero, M Vela, F Cañete, Lucía Márquez, B Velayos, M. Van Domselaar, M Calvo, E Sesé, G Alcaín, M Mora, A Gutiérrez, Y Zabana, Luis Bujanda, J Lázaro, J Martínez-Cadilla, L Arias García, José María Huguet, J Legido, F Bermejo, F Gomollón, M Calafat, R de Francisco, M Barreiro-de-Acosta, C Verdejo, J Riera, F Rodríguez-Moranta, Javier P. Gisbert, E Domènech, P Martínez Montiel, V. García Sánchez, F Argüelles, S García-López, O Roncero, E Garcia-Planella, A M Trapero, C Rodríguez, M F García Sepulcre, D Monfort, and R E Madrigal
- Subjects
medicine.medical_specialty ,business.industry ,Gastroenterology ,Case-control study ,General Medicine ,medicine.disease ,Inflammatory bowel disease ,03 medical and health sciences ,0302 clinical medicine ,Increased risk ,030220 oncology & carcinogenesis ,Internal medicine ,Medicine ,030211 gastroenterology & hepatology ,business ,Adverse effect - Published
- 2018
92. P156 Differential characteristics of patients with inflammatory bowel disease onset in paediatric age compared with patients diagnosed in adulthood: Results from the CAROUSEL study of GETECCU
- Author
-
P Martínez Montiel, A M Trapero Martínez, J L Cabriada, Beatriz Sicilia, L. I. Fernández Salazar, M Menacho, Jesús Barrio, J M Huguet Malavés, A. López-San Román, M Esteve, M Arroyo, X Aldeguer, I Vera Mendoza, L Ramos, Carlos Taxonera, M D Retamero, M Mañosa, A García Herola, J Legido Gil, Olga Merino, J Riera, M F García-Sepulcre, C Rodríguez Gutiérrez, J Acevedo, M Charro, Jordi Guardiola, S Khorrami, E Rodríguez González, M T Novella Durán, R Llorente Poyatos, Á Abad Lacruz, V.M. Navas Lopez, M D Martín Arranz, Javier P. Gisbert, E García-Planella, A Gutiérrez Casbas, L De Castro Parga, F Argüelles, M Piqueras, P Almela, M Mínguez, I Guerra, R Madrigal, M Rivero Tirado, María Chaparro, V J Morales Alvarado, L Márquez, E Sese, A Garre, Jordina Llaó, A Rodríguez, L Hernández Villalba, E Ricart, C. Muñoz Villafranca, R Pajares, P Ramírez de la Piscina, S Riestra, B. Beltrán, A J Lucendo Villarín, E Domènech, V García-Sánchez, O Roncero, Luis Bujanda, G Alcaín, M Navarro-Llavat, Y Ber, Xavier Calvet, S García, M. Barreiro-de Acosta, E Muñoz, J Hinojosa, M. Van Domselaar, P Romero Cara, and J L Pérez Calle
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Gastroenterology ,Medicine ,General Medicine ,Paediatric age ,business ,medicine.disease ,Inflammatory bowel disease - Published
- 2018
93. Chronic prurigo as a onset of Hodgkin's lymphoma
- Author
-
Laura Serra-García, J. Riera-Monroig, Constanza Riquelme-Mc Loughlin, and Constanza Morgado-Carrasco Daniel
- Subjects
medicine.medical_specialty ,Chronic prurigo ,business.industry ,Lymphoma, Non-Hodgkin ,medicine ,Humans ,General Medicine ,Prurigo ,Hodgkin's lymphoma ,medicine.disease ,business ,Dermatology ,Hodgkin Disease - Published
- 2019
94. Persistence of antienvoplakin and antiperiplakin antibodies in a patient with paraneoplastic pemphigus 20 years after remission
- Author
-
Norito Ishii, Pilar Iranzo, J. Riera-Monroig, José M. Mascaró, and Takashi Hashimoto
- Subjects
Persistence (psychology) ,medicine.medical_specialty ,biology ,business.industry ,Paraneoplastic Syndromes ,Dermatology ,medicine.disease ,Antibodies ,Paraneoplastic pemphigus ,medicine ,biology.protein ,Humans ,Antibody ,business ,Pemphigus - Published
- 2019
95. Hedgehog‐like moustache trichomegaly during treatment with vismodegib
- Author
-
A. Rodríguez, J. Ferrando, J. Riera-Monroig, Llucia Alos, C. Mangas, Cristina Carrera, and Andrea Combalia
- Subjects
medicine.medical_specialty ,business.industry ,Vismodegib ,Dermatology ,Infectious Diseases ,medicine.anatomical_structure ,Medicine ,Trichomegaly ,medicine.symptom ,business ,Moustache ,Hedgehog ,medicine.drug - Published
- 2019
96. Editorial: Through a Glass, Darkly: The Influence of the EEG Reference on Inference About Brain Function and Disorders
- Author
-
Paul L. Nunez, Pedro A. Valdes-Sosa, Rui Zhang, Jorge J. Riera, and Maria Luisa Bringas Vega
- Subjects
Rest (physics) ,inference ,medicine.diagnostic_test ,General Neuroscience ,Inference ,Electroencephalography ,ERPs ,reference ,lcsh:RC321-571 ,Editorial ,medicine ,EEG ,average ,rest ,Laplacian ,Psychology ,Neuroscience ,lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry ,Brain function - Published
- 2019
97. Ketogene Diät und Kurzzeitfasten als therapeutische Ergänzung während einer palliativen Chemotherapie beim Bronchialkarzinom
- Author
-
J Riera Knorrenschild, K Brenner, J Thiemer, G Jaques, E Mack, and M Koch
- Published
- 2019
98. Unraveling ChR2-driven stochastic Ca2+ dynamics in astrocytes – A call for new interventional paradigms
- Author
-
Karla A. Montejo, Carolina Moncion, Arash Moshkforoush, Lakshmini Balachandar, and Jorge J. Riera
- Subjects
0301 basic medicine ,Macroglial Cells ,Light ,Physiology ,Channelrhodopsin ,Stimulation ,Endoplasmic Reticulum ,Biochemistry ,Ion Channels ,Cytosol ,0302 clinical medicine ,Cell Signaling ,Global sensitivity analysis ,Animal Cells ,Biology (General) ,Neurons ,Brain Mapping ,0303 health sciences ,Secretory Pathway ,Ecology ,Chemistry ,Physics ,Electromagnetic Radiation ,Dynamics (mechanics) ,Electrophysiology ,On cells ,Bioassays and Physiological Analysis ,medicine.anatomical_structure ,Computational Theory and Mathematics ,Cell Processes ,Modeling and Simulation ,Physical Sciences ,Cellular Types ,Cellular Structures and Organelles ,Algorithms ,Research Article ,Signal Transduction ,Astrocyte ,Cell type ,QH301-705.5 ,Photochemistry ,Central nervous system ,Biophysics ,Neurophysiology ,Glial Cells ,Buffers ,Biology ,Optogenetics ,Research and Analysis Methods ,Membrane Potential ,Cellular and Molecular Neuroscience ,03 medical and health sciences ,Channelrhodopsins ,Genetics ,medicine ,Light sensitive ,Animals ,Computer Simulation ,Calcium Signaling ,Molecular Biology ,Ecology, Evolution, Behavior and Systematics ,Ion channel ,Probability ,030304 developmental biology ,Stochastic Processes ,Experimental model ,fungi ,Wild type ,Biology and Life Sciences ,Proteins ,Computational Biology ,Cell Biology ,Neurophysiological Analysis ,Kinetics ,030104 developmental biology ,Gene Expression Regulation ,Optical stimulation ,Astrocytes ,Calcium ,Calcium Channels ,Neuroscience ,030217 neurology & neurosurgery - Abstract
Optogenetic targeting of astrocytes provides a robust experimental model to differentially induce Ca2+ signals in astrocytes in vivo. However, a systematic study quantifying the response of optogenetically modified astrocytes to light is yet to be performed. Here, we propose a novel stochastic model of Ca2+ dynamics in astrocytes that incorporates a light sensitive component—channelrhodopsin 2 (ChR2). Utilizing this model, we investigated the effect of different light stimulation paradigms on cells expressing select variants of ChR2 (wild type, ChETA, and ChRET/TC). Results predict that depending on paradigm specification, astrocytes might undergo drastic changes in their basal Ca2+ level and spiking probability. Furthermore, we performed a global sensitivity analysis to assess the effect of variation in parameters pertinent to the shape of the ChR2 photocurrent on astrocytic Ca2+ dynamics. Results suggest that directing variants towards the first open state of the ChR2 photocycle (o1) enhances spiking activity in astrocytes during optical stimulation. Evaluation of the effect of Ca2+ buffering and coupling coefficient in a network of ChR2-expressing astrocytes demonstrated basal level elevations in the stimulated region and propagation of calcium activity to unstimulated cells. Buffering reduced the diffusion range of Ca2+ within the network, thereby limiting propagation and influencing the activity of astrocytes. Collectively, the framework presented in this study provides valuable information for the selection of light stimulation paradigms that elicit desired astrocytic activity using existing ChR2 constructs, as well as aids in the engineering of future application-oriented optogenetic variants., Author summary Optogenetics is a novel technique involving the targeted delivery of light-sensitive ion channels like Channelrhodopsin-2 (ChR2) to cells. Recently, this technique has been expanded to non-neuronal cell types, e.g., astrocytes. Optogenetic control of astrocytes in vivo can aid in further understanding the intricacies of their debated roles in the brain. Here, using a mathematical model, we evaluate the effect of short and long-term light stimulation of ChR2-expressing astrocytes on their Ca2+ spiking activity and basal level. We further investigate how ChR2 gating dynamics, buffering, and coupling coefficient of Ca2+ influence astrocytic activity in a single cell and a network. Results of our study can serve as a tool for experimental design and engineering of new application-oriented optogenetic constructs targeting astrocytes.
- Published
- 2019
99. Treatment of 2 Patients With Aquagenic Pruritus With UVA/Narrow Band UVB Combined Therapy Once a Year
- Author
-
D, Morgado-Carrasco, J, Riera-Monroig, H, Feola, and P, Aguilera
- Subjects
Male ,Pruritus ,Humans ,Ultraviolet Therapy - Published
- 2019
100. Controversies in EEG Source Imaging and Connectivity: Modeling, Validation, Benchmarking
- Author
-
Pedro Valdes Sosa, Daniele Marinazzo, Dezhong Yao, Laura Marzetti, Jorge J. Riera, and Laura Astolfi
- Subjects
Radiological and Ultrasound Technology ,medicine.diagnostic_test ,Computer science ,MEDLINE ,Benchmarking ,Electroencephalography ,computer.software_genre ,Source reconstruction ,Neurology ,Granger causality ,medicine ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,Data mining ,Anatomy ,Source imaging ,computer - Published
- 2019
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.